Crism Therapeutics Corporation Ord Npv (CRTX)

Sector:

Investment Firms

Index:

FTSE AIM All-Share

 23.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 23.50p
  • 52 Week Low: 22.00p
  • Currency: UK Pounds
  • Shares Issued: 32.68m
  • Volume: 10,476
  • Market Cap: £7.68m

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
25-Mar-13 HB Markets Buy 8.65p - - New Coverage
07-Aug-12 HB Markets Buy 4.95p - - New Coverage

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

CRTX Market Data

Currency UK Pounds
Share Price 23.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 23.50p
52 Week Low 22.00p
Volume 10,476
Shares Issued 32.68m
Market Cap £7.68m

CRTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
60.77% below the market average60.77% below the market average60.77% below the market average60.77% below the market average60.77% below the market average
73.91% below the sector average73.91% below the sector average73.91% below the sector average73.91% below the sector average73.91% below the sector average
Value
60.77% below the market average60.77% below the market average60.77% below the market average60.77% below the market average60.77% below the market average
73.91% below the sector average73.91% below the sector average73.91% below the sector average73.91% below the sector average73.91% below the sector average
Income Not Available
Growth Not Available

CRTX Dividends

  Latest Previous
  Special Interim
Ex-Div 01-Jun-23 n/a
Paid 14-Jun-23 n/a
Amount 1.80p 0.000¢

Trades for 20-Jun-2025

Time Volume / Share Price
15:45 500 @ 22.00p
14:44 928 @ 22.00p
12:25 9,048 @ 23.40p

CRTX Key Personnel

CEO Andrew James Webb

Top of Page